Halidou Tinto
Last updated on 2014-08-22T19:41+0300.

About this image

Extracted quotes from
Halidou Tinto explained
:
"It is important for us to see if such a vaccine, tested in an area like Nanoro which has a transmission of medium duration, will give the same effectiveness in an area like Dande where the transmission is much longer,"
medicalxpress Wednesday, May 5, 2021 4:29:00 PM EAT
Halidou Tinto afirma
:
“Esses são resultados muito empolgantes. Mostram níveis de eficácia sem precedentes de uma vacina que foi bem tolerada em nosso programa de teste. Estamos ansiosos quanto ao próximo ensaio de fase três para avaliar dados de segurança e eficácia em grande escala, principalmente porque essa é uma vacina que é muito necessária nessa região”
correiobraziliense Saturday, April 24, 2021 12:42:00 PM EAT
Halidou Tinto said
:
"We look forward to the upcoming Phase 3 trial to demonstrate large-scale safety and efficacy data for a vaccine that is greatly needed in this region,"
upi Friday, April 23, 2021 9:58:00 PM EAT
Halidou Tinto wrote
:
“These are very exciting results showing unprecedented efficacy levels from a vaccine that has been well tolerated in our trial program. We look forward to the upcoming phase III trial to demonstrate large-scale safety and efficacy data for a vaccine that is greatly needed in this region,”
abcactionnews Friday, April 23, 2021 8:23:00 PM EAT
Halidou Tinto wrote
:
“These are very exciting results showing unprecedented efficacy levels from a vaccine that has been well tolerated in our trial program. We look forward to the upcoming phase III trial to demonstrate large-scale safety and efficacy data for a vaccine that is greatly needed in this region,”
kxxv Friday, April 23, 2021 8:03:00 PM EAT
Halidou Tinto wrote
:
“These are very exciting results showing unprecedented efficacy levels from a vaccine that has been well tolerated in our trial program. We look forward to the upcoming phase III trial to demonstrate large-scale safety and efficacy data for a vaccine that is greatly needed in this region,”
wkbw Friday, April 23, 2021 8:00:00 PM EAT
Halidou Tinto wrote
:
“These are very exciting results showing unprecedented efficacy levels from a vaccine that has been well tolerated in our trial program. We look forward to the upcoming phase III trial to demonstrate large-scale safety and efficacy data for a vaccine that is greatly needed in this region,”
newschannel5 Friday, April 23, 2021 7:54:00 PM EAT
Halidou Tinto said
:
"These are very exciting results showing unprecedented efficacy levels from a vaccine that has been well tolerated in our trial programme,"
CBSnews Friday, April 23, 2021 7:25:00 PM EAT
Halidou Tinto said
:
"We look forward to the upcoming Phase III trial to demonstrate large-scale safety and efficacy data for a vaccine that is greatly needed in this region,"
CBSnews Friday, April 23, 2021 7:25:00 PM EAT
Halidou Tinto said
:
"These are very exciting results showing unprecedented efficacy levels from a vaccine that has been well tolerated in our trial programme. We look forward to the upcoming phase III trial to demonstrate large-scale safety and efficacy data for a vaccine that is greatly needed in this region,"
PeaceFMGhana Friday, April 23, 2021 12:56:00 PM EAT
Halidou Tinto said
:
“These are very exciting results showing unprecedented efficacy levels from a vaccine that has been well tolerated in our trial programme,”
thenational Friday, April 23, 2021 7:32:00 AM EAT
Key Titles and Phrases | Count | Lang | Last Seen |
---|---|---|---|
médico | 100.00% | PT | 08/13/201413/08/2014 |
Names | Lang | Count |
---|---|---|
Halidou Tinto | FR | 50.00% |
Halidou Tinto | PT | 50.00% |
Type | Entity Name | Count |
---|---|---|
![]() | World Health Organization | 7.08% |
![]() | Oxford University | 4.65% |
![]() | Serum Institute | 3.60% |
![]() | The Lancet | 2.56% |
![]() | Adrian Hill | 2.56% |
![]() | ministère de la Santé | 1.97% |
![]() | Comite | 1.97% |
![]() | United Nations | 1.39% |
![]() | Sidwaya | 1.39% |
![]() | la Communication | 1.28% |
![]() | la Commission | 1.16% |
![]() | Commission | 1.16% |
![]() | CNRS | 1.16% |
![]() | Cyrus Poonawalla | 0.93% |
![]() | Gareth Jenkins | 0.93% |
![]() | No More | 0.93% |
![]() | Lakshmi Mittal | 0.93% |
![]() | Christian Kabore | 0.93% |
![]() | Roch Marc Christian | 0.93% |
![]() | Marc Christian Kabore | 0.93% |
![]() | Roch Marc Christian Kabore | 0.93% |
![]() | ministere de la Recherche | 0.81% |
![]() | L Equipe | 0.81% |
![]() | CE | 0.81% |
![]() | Burkina-Faso | 0.81% |
![]() | Barrie Bignold | 0.81% |
![]() | Private Ltd | 0.81% |
![]() | India Private Ltd | 0.81% |
![]() | European Union | 0.81% |
![]() | Inc | 0.81% |
Type | Entity Name | Score |
---|---|---|
![]() | Serum Institute | 0.0323 |
![]() | Oxford University | 0.0302 |
![]() | Georges Guiella | 0.0238 |
![]() | Adrian Hill | 0.0223 |
![]() | The Lancet | 0.0182 |
![]() | Valentin Agon | 0.0152 |
![]() | ministère de la Santé | 0.0135 |
![]() | Comite | 0.0125 |
![]() | Alfred Jones | 0.0124 |
![]() | Bernard Sawadogo | 0.0116 |
![]() | Sidwaya | 0.0102 |
![]() | Christian Felix | 0.0098 |
![]() | World Health Organization | 0.0091 |
![]() | la Communication | 0.009 |
![]() | CNRS | 0.0084 |
![]() | Cyrus Poonawalla | 0.0081 |
![]() | Gareth Jenkins | 0.0081 |
![]() | No More | 0.008 |
![]() | Lakshmi Mittal | 0.008 |
![]() | Ousmane Dao | 0.0076 |
![]() | Abou Traore | 0.0076 |
![]() | Roch Marc Christian Kabore | 0.0071 |
![]() | Christian Kabore | 0.007 |
![]() | Roch Marc Christian | 0.007 |
![]() | Marc Christian Kabore | 0.007 |
![]() | India Private Ltd | 0.007 |
![]() | ministere de la Recherche | 0.0069 |
![]() | Burkina-Faso | 0.0069 |
![]() | Private Ltd | 0.0069 |
![]() | Francis Ducreux | 0.0069 |


Tools
Select your languages
Interface:
Explore Relations
The selection and placement of stories are determined automatically by a computer program.
This site is supplied by the Situation Room of the Continental Early Warning System (CEWS) of the Peace and Security Department of the African Union Commission. The project is supported by the Joint Research Centre of the EU Commission
Please send any comments or suggestions to
The information on this site is subject to adisclaimer.